Variant report

Variant	nsv970174
Chromosome Location	chr6:150262064-150263659
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:197)
CpG islands
(count:733)
Chromatin interactive
region (count:3)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:197 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr6:150262888-150263243	K562	blood:	n/a	n/a
2	BACH1	chr6:150263349-150263435	H1-hESC	embryonic stem cell:	n/a	n/a
3	BHLHE40	chr6:150262692-150263290	K562	blood:	n/a	n/a
4	CBX3	chr6:150262653-150263485	K562	blood:	n/a	n/a
5	CCNT2	chr6:150262706-150263315	K562	blood:	n/a	n/a
6	CHD2	chr6:150262809-150263101	H1-hESC	embryonic stem cell:	n/a	n/a
7	CHD2	chr6:150262728-150263178	K562	blood:	n/a	n/a
8	CHD2	chr6:150262779-150263173	GM12878	blood:	n/a	n/a
9	CREB1	chr6:150262823-150263345	GM12878	blood:	n/a	n/a
10	CREB1	chr6:150262805-150263335	ECC-1	luminal epithelium:	n/a	n/a
11	CREB1	chr6:150262830-150263355	H1-hESC	embryonic stem cell:	n/a	n/a
12	CREB1	chr6:150262830-150263246	A549	lung:	n/a	n/a
13	CTBP2	chr6:150262374-150263823	H1-hESC	embryonic stem cell:	n/a	n/a
14	CTCF	chr6:150263600-150263750	HA-sp	spinal cord:	n/a	n/a
15	CTCF	chr6:150263600-150263750	HBMEC	blood vessel:	n/a	n/a
16	CTCF	chr6:150263560-150263710	HMEC	breast:	n/a	n/a
17	CTCF	chr6:150263600-150263750	HEK293	kidney:	n/a	n/a
18	CTCF	chr6:150263620-150263770	HBMEC	blood vessel:	n/a	n/a
19	CTCF	chr6:150263260-150263410	HRE	kidney:	n/a	n/a
20	CTCF	chr6:150263600-150263750	AG04450	lung:	n/a	n/a
21	CTCF	chr6:150263360-150263510	AG04449	skin:	n/a	chr6:150263436-150263449
22	CTCF	chr6:150263160-150263310	HCPEpiC	choroid plexus:	n/a	n/a
23	CTCF	chr6:150263320-150263470	HCPEpiC	choroid plexus:	n/a	chr6:150263436-150263449
24	CTCF	chr6:150263240-150263390	AG04449	skin:	n/a	n/a
25	CTCF	chr6:150263600-150263750	HUVEC	blood vessel:	n/a	n/a
26	CTCF	chr6:150263280-150263430	BJ	skin:	n/a	n/a
27	CTCF	chr6:150263140-150263290	SK-N-SH_RA	brain:	n/a	n/a
28	CTCF	chr6:150263600-150263750	NHEK	skin:	n/a	n/a
29	CTCF	chr6:150263240-150263390	AG04450	lung:	n/a	n/a
30	CTCF	chr6:150263120-150263270	GM12874	blood:	n/a	n/a
31	CTCF	chr6:150263580-150263730	HUVEC	blood vessel:	n/a	n/a
32	CTCF	chr6:150263620-150263770	HAc	cerebellar:	n/a	n/a
33	CTCF	chr6:150263620-150263770	BJ	skin:	n/a	n/a
34	CTCF	chr6:150263600-150263750	AG04449	skin:	n/a	n/a
35	CTCF	chr6:150263620-150263770	HCFaa	heart:	n/a	n/a
36	CTCF	chr6:150263600-150263750	HPAF	blood vessel:	n/a	n/a
37	CTCF	chr6:150263300-150263450	AG09319	gingival:	n/a	chr6:150263436-150263449
38	CTCF	chr6:150263062-150263125	GM12878	blood:	n/a	n/a
39	CTCF	chr6:150263140-150263290	HA-sp	spinal cord:	n/a	n/a
40	CTCF	chr6:150263600-150263750	BJ	skin:	n/a	n/a
41	CTCF	chr6:150263600-150263750	AoAF	blood vessel:	n/a	n/a
42	CTCF	chr6:150263500-150263750	HRE	kidney:	n/a	n/a
43	CTCF	chr6:150263380-150263530	HA-sp	spinal cord:	n/a	chr6:150263436-150263449
44	CTCF	chr6:150263000-150263150	AG04449	skin:	n/a	n/a
45	CTCF	chr6:150262940-150263090	HUVEC	blood vessel:	n/a	n/a
46	E2F4	chr6:150262902-150263292	MCF10A-Er-Src	breast:	n/a	chr6:150263107-150263116 chr6:150263043-150263052 chr6:150263097-150263104 chr6:150263097-150263104 chr6:150263097-150263104
47	E2F6	chr6:150262683-150262854	K562	blood:	n/a	n/a
48	E2F6	chr6:150262667-150263364	K562	blood:	n/a	chr6:150263107-150263116 chr6:150263043-150263052 chr6:150263097-150263104 chr6:150262855-150262865 chr6:150263097-150263104 chr6:150263097-150263104
49	E2F6	chr6:150262665-150263318	A549	lung:	n/a	chr6:150263107-150263116 chr6:150263043-150263052 chr6:150263097-150263104 chr6:150262855-150262865 chr6:150263097-150263104 chr6:150263097-150263104
50	E2F6	chr6:150262969-150263268	K562	blood:	n/a	chr6:150263107-150263116 chr6:150263043-150263052 chr6:150263097-150263104 chr6:150263097-150263104 chr6:150263097-150263104

(count:733 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:150262771-150262821	AG10803	skin:	n/a
2	chr6:150262771-150262821	AG10803	skin:	n/a
3	chr6:150263194-150263244	HEEpiC	esophagus:	n/a
4	chr6:150262044-150262094	HAEpiC	amniotic membrane:	n/a
5	chr6:150262961-150263011	U87	brain:	n/a
6	chr6:150262961-150263011	NHDF-neo	bronchial:	n/a
7	chr6:150262763-150262813	HMEC	breast:	n/a
8	chr6:150263354-150263404	HMEC	breast:	n/a
9	chr6:150262763-150262813	Jurkat	blood:	n/a
10	chr6:150262044-150262094	NHBE	bronchial:	n/a
11	chr6:150263488-150263538	HNPCEpiC	eye:	n/a
12	chr6:150263354-150263404	IMR90	lung:	fetal
13	chr6:150262734-150262784	HepG2	liver:	n/a
14	chr6:150262044-150262094	HPAEpiC	pulmonary alveolar:	n/a
15	chr6:150262965-150263015	AG04449	skin:	fetal
16	chr6:150262965-150263015	H1-hESC	embryonic stem cell:	embryo
17	chr6:150263354-150263404	HPAEpiC	pulmonary alveolar:	n/a
18	chr6:150262734-150262784	HRPEpiC	eye:	n/a
19	chr6:150262961-150263011	AG10803	skin:	n/a
20	chr6:150263194-150263244	H1-hESC	embryonic stem cell:	embryo
21	chr6:150262734-150262784	RPTEC	kidney:	n/a
22	chr6:150263070-150263120	NHDF-neo	bronchial:	n/a
23	chr6:150263118-150263168	NHDF-neo	bronchial:	n/a
24	chr6:150263488-150263538	BJ	skin:	n/a
25	chr6:150263070-150263120	NH-A	brain:	n/a
26	chr6:150262965-150263015	AoSMC	blood vessel:	n/a
27	chr6:150262961-150263011	SK-N-MC	brain:	n/a
28	chr6:150263035-150263085	GM12891	blood:	n/a
29	chr6:150262961-150263011	SK-N-SH	brain:	n/a
30	chr6:150263488-150263538	A549	lung:	n/a
31	chr6:150262044-150262094	NHDF-neo	bronchial:	n/a
32	chr6:150263070-150263120	NT2-D1	testis:	n/a
33	chr6:150263354-150263404	HAEpiC	amniotic membrane:	n/a
34	chr6:150263035-150263085	HRPEpiC	eye:	n/a
35	chr6:150263354-150263404	PrEC	prostate:	n/a
36	chr6:150262771-150262821	HRPEpiC	eye:	n/a
37	chr6:150263354-150263404	MCF-7	breast:	n/a
38	chr6:150262763-150262813	SKMC	muscle:	n/a
39	chr6:150262763-150262813	MCF-7	breast:	n/a
40	chr6:150263194-150263244	GM06990	blood:	n/a
41	chr6:150262771-150262821	SK-N-MC	brain:	n/a
42	chr6:150262734-150262784	AG04449	skin:	fetal
43	chr6:150263488-150263538	SAEC	small airway:	n/a
44	chr6:150262961-150263011	A549	lung:	n/a
45	chr6:150262763-150262813	HPAEpiC	pulmonary alveolar:	n/a
46	chr6:150262763-150262813	NB4	blood:	n/a
47	chr6:150262961-150263011	GM12878	blood:	n/a
48	chr6:150262734-150262784	SKMC	muscle:	n/a
49	chr6:150263194-150263244	HepG2	liver:	n/a
50	chr6:150262734-150262784	LNCaP	prostate:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:150255655..150257664-chr6:150259479..150262477,4	K562	blood:
2	chr6:150254783..150257862-chr6:150259479..150262603,4	K562	blood:
3	chr6:150263150..150264777-chr6:150325600..150328449,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ULBP2-1	chr6:150261044-150262631	XLOC_005501
2	lnc-ULBP2-1	chr6:150261044-150262631	XLOC_005501
3	lnc-ULBP2-1	chr6:150261044-150262766	NONHSAT115525

No data

Variant related genes	Relation type
ULBP2	TF binding region
ULBP2	CpG island
ENSG00000216621	chromatin interactions
ENSG00000218358	chromatin interactions
VPS36	miRNA target sites
ARID1B	miRNA target sites

Extended variants
information (count: 84 )
Associated
traits (count: 82 )

Variant overlapped rSNPs/rCNVs (count:84 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs17079076	chr6:150262097-150262098	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs541418256	chr6:150262179-150262180	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
3	rs192352241	chr6:150262219-150262220	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
4	rs371924836	chr6:150262226-150262227	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
5	rs528331821	chr6:150262227-150262228	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
6	rs144821711	chr6:150262263-150262264	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
7	rs568301926	chr6:150262268-150262269	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
8	rs151285634	chr6:150262275-150262276	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
9	rs11969347	chr6:150262314-150262315	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs376574006	chr6:150262364-150262365	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
11	rs570134858	chr6:150262368-150262369	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
12	rs539149981	chr6:150262384-150262385	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
13	rs34347132	chr6:150262402-150262403	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
14	rs185633355	chr6:150262480-150262481	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
15	rs572407677	chr6:150262484-150262485	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
16	rs535729617	chr6:150262487-150262488	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
17	rs541113530	chr6:150262497-150262498	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
18	rs555228174	chr6:150262505-150262506	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
19	rs117316059	chr6:150262526-150262527	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
20	rs543583324	chr6:150262542-150262543	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
21	rs12529548	chr6:150262546-150262547	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
22	rs563556452	chr6:150262566-150262567	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
23	rs532040783	chr6:150262589-150262590	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
24	rs140503205	chr6:150262595-150262596	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
25	rs113820585	chr6:150262661-150262662	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
26	rs559232407	chr6:150262679-150262680	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
27	rs571861301	chr6:150262688-150262689	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
28	rs375562064	chr6:150262689-150262690	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
29	rs528082368	chr6:150262697-150262698	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
30	rs372798225	chr6:150262705-150262706	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
31	rs568321338	chr6:150262717-150262718	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
32	rs114839655	chr6:150262736-150262737	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
33	rs150416854	chr6:150262757-150262758	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
34	rs570257909	chr6:150262763-150262764	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
35	rs4133317	chr6:150262786-150262787	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs539088927	chr6:150262801-150262802	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
37	rs76916952	chr6:150262811-150262812	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
38	rs566075676	chr6:150262820-150262821	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs71568295	chr6:150262829-150262830	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs534995592	chr6:150262859-150262860	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs376292706	chr6:150262864-150262865	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs554689706	chr6:150262900-150262901	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs531361492	chr6:150262912-150262913	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs75355357	chr6:150262914-150262915	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs187775675	chr6:150262920-150262921	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs386706966	chr6:150262994-150262995	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
47	rs201937035	chr6:150262996-150262997	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
48	rs546031008	chr6:150263018-150263019	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs74642874	chr6:150263030-150263031	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs528200008	chr6:150263064-150263065	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:82)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Autism	22495311	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
Renal cell carcinoma	18592004	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Malignant melanoma	17260012	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Soft tissue tumor	16732325	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
Cancer	17160897	CNVD
Breast cancer	17417639	CNVD
Breast cancer	17850661	CNVD
Renal cell carcinoma	18765545	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Ovarian neoplasms	16753589	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20556506	CNVD
Hirschsprung''s Disease	21712996	CNVD
Testicular germ cell tumor	18059402	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:308 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:150260200-150262600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
2	chr6:150260400-150262200	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
3	chr6:150260400-150262400	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
4	chr6:150260400-150262600	Weak transcription	Right Atrium	heart
5	chr6:150260400-150262600	Weak transcription	HMEC	breast
6	chr6:150260600-150262200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
7	chr6:150260600-150262400	Weak transcription	Pancreas	Pancrea
8	chr6:150260600-150262400	Weak transcription	Right Ventricle	heart
9	chr6:150260800-150262400	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
10	chr6:150261400-150262400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
11	chr6:150261400-150264000	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
12	chr6:150261600-150262200	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
13	chr6:150261600-150262400	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
14	chr6:150261600-150262600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
15	chr6:150261800-150262200	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
16	chr6:150261800-150262200	Bivalent Enhancer	Brain Dorsolateral Prefrontal Cortex	brain
17	chr6:150261800-150262400	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
18	chr6:150261800-150262400	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
19	chr6:150261800-150262400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
20	chr6:150261800-150262400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr6:150261800-150262600	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
22	chr6:150261800-150262600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
23	chr6:150261800-150262600	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
24	chr6:150261800-150263200	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr6:150262000-150262200	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
26	chr6:150262000-150262400	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
27	chr6:150262000-150262400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
28	chr6:150262000-150262400	Bivalent Enhancer	Brain Anterior Caudate	brain
29	chr6:150262000-150262400	Bivalent Enhancer	Brain Germinal Matrix	brain
30	chr6:150262000-150262400	Bivalent Enhancer	Fetal Muscle Leg	muscle
31	chr6:150262000-150262600	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
32	chr6:150262200-150262400	Bivalent Enhancer	Primary B cells from cord blood	blood
33	chr6:150262200-150262400	Bivalent Enhancer	Adipose Nuclei	Adipose
34	chr6:150262200-150262600	Enhancers	Primary T helper cells PMA-I stimulated	--
35	chr6:150262200-150262600	Bivalent Enhancer	Fetal Thymus	thymus
36	chr6:150262200-150262800	Bivalent Enhancer	Primary hematopoietic stem cells	blood
37	chr6:150262200-150263200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
38	chr6:150262400-150262600	Flanking Bivalent TSS/Enh	H9 Derived Neuron Cultured Cells	ES cell derived
39	chr6:150262400-150262600	Bivalent/Poised TSS	IMR90 fetal lung fibroblasts Cell Line	lung
40	chr6:150262400-150262600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
41	chr6:150262400-150262600	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
42	chr6:150262400-150262600	Enhancers	Primary B cells from cord blood	blood
43	chr6:150262400-150262600	Active TSS	Primary T cells from cord blood	blood
44	chr6:150262400-150262600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
45	chr6:150262400-150262600	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
46	chr6:150262400-150262600	Flanking Bivalent TSS/Enh	Primary T regulatory cells fromperipheralblood	blood
47	chr6:150262400-150262600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
48	chr6:150262400-150262600	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
49	chr6:150262400-150262600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
50	chr6:150262400-150262600	Flanking Active TSS	Brain Anterior Caudate	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links